Evidence map›Paper›PMID 34068497›Full record

ArticleJournal of clinical medicine2021

Prospective Measures of Adherence by Questionnaire, Low Immunosuppression and Graft Outcome in Kidney Transplantation.

Mathilde Prezelin-Reydit, Valérie Dubois, Sophie Caillard, Anne Parissiadis, Isabelle Etienne, Françoise Hau, Laetitia Albano, Monique Pourtein, Benoît Barrou, Jean-Luc Taupin and 9 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mathilde Prezelin-ReyditService de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, 33076 Bordeaux, France.ORCID 0000-0001-8302-7783
Valérie DuboisCIRI, INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon I, 21, avenue Tony Garnier, 69007 Lyon, France.ORCID 0000-0002-1169-7697
Sophie CaillardNephrology-Transplantation Department, University Hospital, 1 Place de l'hôpital BP426, CEDEX, 67091 Strasbourg, France.
Anne ParissiadisHistocompatibility Laboratory, UMR-S949 Inserm, Etablissement Français du Sang, 67000 Strasbourg, France.
Isabelle EtienneNephrology Department, CHU Rouen, 76000 Rouen, France.
Françoise HauLaboratory of Histocompatibility, EFS Hauts-de-France Normandie, 76000 Rouen, France.
Laetitia AlbanoService de Néphrologie-Dialyse-Transplantation, CHU de Nice, Université Côte d'Azur, 06000 Nice, France.
Monique PourteinDepartment of Immunology, Centre Hospitalier Universitaire de Nice, University Hospital of Nice, 06000 Nice, France.
Benoît BarrouDepartment of Renal Transplantation, INSERM U 1082, Sorbonne Université, Pitié-Salpêtrière, 75013 Paris, France.
Jean-Luc TaupinLaboratory of Immunology and Histocompatibility, Hôpital Saint-Louis APHP, 75010 Paris, France.
Christophe MariatNephrology Department, CHU de Saint-Etienne, Groupe Immunité Muqueuse et Agents Pathogènes (GIMAP), Jean Monnet University, Université de Lyon, 42100 Saint-Etienne, France.
Léna AbsiLaboratoire d'Immunologie, EFS Loire-Auvergne, 25 Boulevard Pasteur, 42100 Saint-Etienne, France.
Cécile VigneauInserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Univ Rennes, CHU Rennes, 35000 Rennes, France.
Virginie RenacHLA-HPA Laboratory, 35016 Rennes, France.ORCID 0000-0002-4429-4421
Gwendaline GuidicelliService d'Immunologie et Immunogénétique, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, 33000 Bordeaux, France.
Jonathan VisentinService d'Immunologie et Immunogénétique, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, 33000 Bordeaux, France.
Pierre MervilleService de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, 33076 Bordeaux, France.ORCID 0000-0001-8987-2929
Olivier ThaunatCIRI, INSERM U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon I, 21, avenue Tony Garnier, 69007 Lyon, France.ORCID 0000-0002-3648-8963
Lionel CouziService de Néphrologie-Transplantation-Dialyse-Aphérèse, Hôpital Pellegrin, CHU de Bordeaux Pellegrin, 33076 Bordeaux, France.ORCID 0000-0002-9213-6196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-adherence with immunosuppressant medication (MNA) fosters development of de novo donor-specific antibodies (

methodsWe enrolled 301 KTRs in a multicentric French study. MNA was assessed prospectively at 3, 6, 12, and 24 months (M) post-KT, using the Morisky scale. We investigated the association between MNA and occurrence of

resultsThe initial percentage of MNA patients was 17.7%, increasing to 34.6% at 24 months. Nineteen patients (8.4%) developed

conclusionsProspective serial monitoring of MNA using the Morisky scale does not predict

Indexed as

adherencednDSAgraft survivalimmunosuppressionkidney transplantation

Identifiers

PMID34068497
PMCPMC8125965

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.